109
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Improving the Reliability Between the BODE Index and the BODS Index in Which the 6-Min Walk Test Was Replaced with the Five-Repetition Sit-to-Stand Test

ORCID Icon, , &
Pages 643-652 | Published online: 29 Mar 2022

References

  • Fermont JM, Masconi KL, Jensen MT, et al. Biomarkers and clinical outcomes in COPD: a systematic review and meta-analysis. Thorax. 2019;74(5):439–446. doi:10.1136/thoraxjnl-2018-211855
  • Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370:765–773. doi:10.1016/S0140-6736(07)61380-4
  • Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350:1005–1012.
  • Puhan MA, Garcia-Aymerich J, Frey M, et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet. 2009;374:704–711. doi:10.1016/S0140-6736(09)61301-5
  • Jones RC, Donaldson GC, Chavannes NH, et al. Derivation and validation of a composite index of severity in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009;180:1189–1195. doi:10.1164/rccm.200902-0271OC
  • Boeck L, Soriano JB, Brusse-Keizer M, et al. Prognostic assessment in COPD without lung function: the B-AE-D indices. Eur Respir J. 2016;47(6):1635–1644. doi:10.1183/13993003.01485-2015
  • Bellou V, Belbasis L, Konstantinidis AK, et al. Prognostic models for outcome prediction in patients with chronic obstructive pulmonary disease: systematic review and critical appraisal. BMJ. 2019;367:5358. doi:10.1136/bmj.l5358
  • Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of COPD; 2020. Available from: http://www.goldcopd.org/. Accessed March, 2020.
  • Soler-Cataluña JJ, Martínez-García MA, Sánchez LS, et al. Severe exacerbations and BODE index: two independent risk factors for death in male COPD patients. Respir Med. 2009;103:692–699. doi:10.1016/j.rmed.2008.12.005
  • Fermont JM, Mohan D, Fisk M, et al. Short physical performance battery as a practical tool to assess mortality risk in chronic obstructive pulmonary disease. Age Ageing. 2021;50(3):795–801. doi:10.1093/ageing/afaa138
  • Jones S, Nolan C, Patel S, et al. Development of a new prognosis index (BODS) in patients with COPD: a prospective cohort study. Eur Respir J. 2018;52(Suppl. 62):PA832.
  • Jones S, Nolan C, Patel S, et al. Five-repetition sit-to-stand and mortality in COPD: a prospective cohort study. Eur Respir J. 2018;52(Suppl. 62):OA1623.
  • Puhan MA, Siebeling L, Zoller M, et al. Simple functional performance tests and mortality in COPD. Eur Respir J. 2013;42(4):956–963. doi:10.1183/09031936.00131612
  • Vaidya T, Chambellan A, de Bisschop C. Sit-to-stand tests for COPD: a literature review. Respir Med. 2017;128:70–77. doi:10.1016/j.rmed.2017.05.003
  • Zhang Q, Li YX, Li XL, et al. A comparative study of the five-repetition sit-to-stand test and the 30-second sit-to-stand test to assess exercise tolerance in COPD patients. Int J Chron Obstruct Pulmon Dis. 2018;13:2833–2839. doi:10.2147/COPD.S173509
  • Bernabeu-Mora R, Medina-Mirapeix F, Llamazares-Herrán E, et al. The accuracy with which the 5 times sit-to-stand test, versus gait speed, can identify poor exercise tolerance in patients with COPD: a cross-sectional study. Medicine. 2016;95:35. doi:10.1097/MD.0000000000004740
  • Lange P, Marott JL, Vestbo J, et al. Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population. Am J Respir Crit Care Med. 2012;186(10):975–981. doi:10.1164/rccm.201207-1299OC
  • Mahler D, Wells C. Evaluation of clinical methods for rating dyspnea. Chest. 1988;93:580–586. doi:10.1378/chest.93.3.580
  • American Thoracic Society Statement. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis. 1991;144:1202–1218. doi:10.1164/ajrccm/144.5.1202
  • ATS statement: guidelines for the six-minute walk test. ATS Committee on proficiency standards for clinical pulmonary function laboratories. Am J Respir Crit Care Med. 2002;166:111–117. doi:10.1164/ajrccm.166.1.at1102
  • Guralnik JM. Assessing physical performance in the older patient [CDROM]. Bethesda, MD: National Institutes of Aging. Available from: http://www.grc.nia.nih.gov/branches/leps/sppb/. Accessed February 8, 2020.
  • McGarvey LP, John M, Anderson JA, et al. Ascertainment of cause-specific mortality in COPD: operations of the TORCH clinical endpoint committee. Thorax. 2007;62:411–415. doi:10.1136/thx.2006.072348
  • Almagro P, Calbo E, Ochoa de Echaguïen A, et al. Mortality after hospitalization for COPD. Chest. 2002;121:1441–1448. doi:10.1378/chest.121.5.1441
  • Groenewegen KH, Schols AM, Wouters E. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest. 2003;124:459–467. doi:10.1378/chest.124.2.459
  • Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159–174. doi:10.2307/2529310
  • Vieira EB, Degani-Costa LH, Amorim BC, et al. Modified BODE index to predict mortality in individuals with COPD: the role of 4-min step test. Respir Care. 2020;65(7):977–983. doi:10.4187/respcare.06991
  • Sullivan LM, Massaro JM, D’Agostino RB. Presentation of multivariate data for clinical use: the Framingham Study risk score functions. Stat Med. 2004;23(10):1631–1660. doi:10.1002/sim.1742
  • Martinez FJ, Han MK, Andrei AC, et al. Longitudinal change in the BODE index predicts mortality in severe emphysema. Am J Respir Crit Care Med. 2008;178:491–499. doi:10.1164/rccm.200709-1383OC
  • Norman K, Stobäus N, Zocher D, et al. Cutoff percentiles of bioelectrical phase angle predict functionality, quality of life, and mortality in patients with cancer. Am J Clin Nutr. 2010;92(3):612–619. doi:10.3945/ajcn.2010.29215
  • Pezzuto A, Stellato M, Gioovanna C, et al. Short-term benefit of smoking cessation along with glycopirronium on lung function and respiratory symptoms in mild COPD patients: a retrospective study. J Breath Res. 2018;12(4):046007. doi:10.1088/1752-7163/aad0a8
  • Mason SE, Moreta-Martínez R, Labaki WW, et al. Longitudinal association between muscle loss and mortality in ever-smokers. Chest. 2021;S0012-3692(21)04290-2. doi:10.1016/j.chest.2021.10.047